000788.SZ
PKU HealthCare Corp., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.51
−2.13%Sep 2, 2026, 10:43 UTC
Southwest Synthetic Pharmaceutical Group, a shareholder holding over 5% of Peking University Pharmaceutical, had 1% of the company's shares (5.96 million shares) forcibly sold by Zhongtai Securities via centralized bidding from August 5 to September 1, 2026, due to a margin trading dispute, reducing its stake to 20.22%.
Aug 24, 2026, 13:11 UTC
Peking University Founder Pharmaceutical Co., Ltd. proposed a cash dividend of 0.20 yuan per 10 shares (tax included) based on 596 million shares, with no bonus shares and no capital reserve conversion.
Source:Aug 24, 2026, 13:11 UTC
Peking University Founder Pharmaceutical Co., Ltd. announced its first-half 2026 results: revenue of 447 million yuan, down 53.30% year-on-year; net profit attributable to shareholders of 55.6708 million yuan, down 44.49% year-on-year; non-recurring net profit of 43.3238 million yuan, down 55.87% year-on-year.
Source:Jul 21, 2026, 10:14 UTC
A court in Jinan ordered the judicial enforcement of 17,879,622 shares held by Southwest Synthetic Pharmaceutical Group Co., Ltd. in Peking University Pharmaceutical Co., Ltd. due to a margin trading dispute.
Source: